Tag
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.
As part of Be Medicinewise Week, Australians are being urged to keep accurate lists of all our medications to avoid harmful interactions and overdoses.